This site will look much better in a browser that supports web standards, but it is accessible to any browser or Internet device.

Skip Navigation skip menu and banner
University of Wyoming

Past Meeting Information
April 14, 2009 Meeting

Agenda
Minutes
Ophthalmic NSAIDs
Ophthalmic Glaucoma Agents
Ophthalmic Antibiotics

 

February 10, 2009
Agenda
Minutes


Drug Categories and Reports

Asthma drugs:  beta agonists, inhaled corticosteroids, leukotriene modifiers

                    Asthma Final Evidence Tables
                    Asthma Final Executive Summary
                    Asthma Final Report
                    QRMA Final Evidence Tables Update
                    QRMA Final Executive Summary Update
                    QRMA Final Report Update

Nasal corticosteroids

                    NCS Final Report Update

Ophthalmic antihistamines

                    OP Conjunctivitis Final

October 15, 2008
Agenda, October 15, 2008
Minutes
Atypical Antipsychotic - Final Report
Atypical Antipsychotic - Evidence Tables
Atypical Antipsychotic - Executive Summary
ADHD - Final Report
ADHD - Evidence Tables
ADHD - Executive Summary

June 4, 2008
Agenda 
Minutes
Angiotensin II Receptor Antagonists Final Report
Angiotensin II Receptor Antagonists Final Evidence Tables
Antiplatelet Agents Final Report
 Antiplatelet Agents Final Evidence Tables
Opioids Final Report
Opioids Final Evidence Tables
Triptans Final Report

October 10, 2007
Agenda
Minutes
Beta Blockers Final Evidence Tables
Beta Blockers Final Report
Insomnia Drugs Final Evidence Tables
Insomnia Drugs Final Report

April 11, 2007
 Agenda April 11 2007  (revised April 3, 2007)
Minutes April 11 2007
Antidepressant Update Brief 12 06
Antidepressant Update Final 9 06
NSAIDs Final Evidence Tables
NSAIDs Final Report

October 11, 2006
Agenda 10-11-06  REVISED 10/2/06
Minutes October 11 2007
ADHD Final Report
ADHD Final Report Evidence Tables
PPIs Final Report
PPIs Final Report Evidence Tables
Opioids Final Report
Statins Final Report
Statins Final Report Evidence Tables

April 12, 2006
 Agenda
Minutes
Triptans Final Report
OAB Final Report
Newer antihistamines Final Report Update 1 
Newer Antihistamines Final Report Update 1 Evidence Tables

October 5, 2005
Agenda
Minutes
 

June 1, 2005
Agenda
Minutes

December 2, 2004
 Agenda
 Minutes
 2nd Generation Antihistamines Final Report

October 21, 2004
 Agenda
 Minutes
CCB Final Report
Opioids Final Report
SMR Final Report
 Statins Final Report

April 15, 2004
 Agenda
Minutes
Evidence-Based Reviews From Oregon
Drug Class Review on Proton Pump Inhibitors
Drug Class Review on HMG-CoA Reductase Inhibitors (Statins)
 Drug Class Review on Cyclo-oxygenase (COX)-2 Inhibitors and Non-steroidal Anti-inflammatory Drugs (NSAIDs)

October 30, 2003
 Agenda
 Minutes Morning Session
Minutes Afternoon Session
 Evidence-Based Reviews From Oregon
 Ace Inhibitors - Draft Report
Ace Inhibitors - Executive Summary
Proton Pump Inhibitors - Final Report
 Proton Pump Inhibitors - Executive Summary

October 24, 2003
 Minutes